Feasibility of Modified Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy : A Retrospective Analysis
© 2022 S. Karger AG, Basel..
BACKGROUND: Endobronchial ultrasound (EBUS)-guided intranodal forceps biopsy (IFB), a diagnostic bronchoscopic technique for intrathoracic lymphadenopathy, is performed following EBUS-guided transbronchial needle aspiration (TBNA). The current EBUS-IFB technique is complex and provides small sample volumes. We modified this technique to allow the use of standard-sized forceps.
OBJECTIVES: The aim of this study was to assess the feasibility of the modified EBUS-IFB technique, which combines standard-sized forceps with standard EBUS-TBNA equipment.
METHOD: This retrospective analysis included consecutive patients scheduled for EBUS-TBNA with attempted additional IFB between July 2020 and March 2021. The feasibility indices of IFB, technical success rate, diagnostic accuracy, and major complications were retrospectively investigated. We performed semi-quantitative evaluation of the histological specimens and univariable analyses to identify factors associated with IFB failure.
RESULTS: During the study period, 295 patients underwent 307 EBUS-TBNAs; 195 cases were included in the analyses. Target lesions were mainly mediastinal lymph nodes (134 cases, 68.7%); the most frequent sites were #7 (61 cases) and #4R (50 cases). The median lesion size was 16.1 mm, the technical IFB success rate was 90.8%, and the diagnostic accuracy of the TBNA and IFB combination was 99.5%. One patient was lost to follow-up. Univariable analyses did not identify any factors involved in technical IFB failure. Major complications of pneumonia and pneumothorax occurred in 2 cases (1.0%). The median histological score was significantly higher in the IFB group than in the TBNA group (1.67 vs. 1.50, p = 0.032).
CONCLUSIONS: Modified EBUS-IFB, combining standard-sized forceps with common EBUS-TBNA equipment, is feasible with few major complications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
Respiration; international review of thoracic diseases - 102(2023), 2 vom: 20., Seite 143-153 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Konno-Yamamoto, Aya [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bronchoscopy |
---|
Anmerkungen: |
Date Completed 07.02.2023 Date Revised 03.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1159/000528644 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350547351 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350547351 | ||
003 | DE-627 | ||
005 | 20231226045239.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000528644 |2 doi | |
028 | 5 | 2 | |a pubmed24n1168.xml |
035 | |a (DE-627)NLM350547351 | ||
035 | |a (NLM)36543151 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Konno-Yamamoto, Aya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Feasibility of Modified Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy |b A Retrospective Analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.02.2023 | ||
500 | |a Date Revised 03.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 S. Karger AG, Basel. | ||
520 | |a BACKGROUND: Endobronchial ultrasound (EBUS)-guided intranodal forceps biopsy (IFB), a diagnostic bronchoscopic technique for intrathoracic lymphadenopathy, is performed following EBUS-guided transbronchial needle aspiration (TBNA). The current EBUS-IFB technique is complex and provides small sample volumes. We modified this technique to allow the use of standard-sized forceps | ||
520 | |a OBJECTIVES: The aim of this study was to assess the feasibility of the modified EBUS-IFB technique, which combines standard-sized forceps with standard EBUS-TBNA equipment | ||
520 | |a METHOD: This retrospective analysis included consecutive patients scheduled for EBUS-TBNA with attempted additional IFB between July 2020 and March 2021. The feasibility indices of IFB, technical success rate, diagnostic accuracy, and major complications were retrospectively investigated. We performed semi-quantitative evaluation of the histological specimens and univariable analyses to identify factors associated with IFB failure | ||
520 | |a RESULTS: During the study period, 295 patients underwent 307 EBUS-TBNAs; 195 cases were included in the analyses. Target lesions were mainly mediastinal lymph nodes (134 cases, 68.7%); the most frequent sites were #7 (61 cases) and #4R (50 cases). The median lesion size was 16.1 mm, the technical IFB success rate was 90.8%, and the diagnostic accuracy of the TBNA and IFB combination was 99.5%. One patient was lost to follow-up. Univariable analyses did not identify any factors involved in technical IFB failure. Major complications of pneumonia and pneumothorax occurred in 2 cases (1.0%). The median histological score was significantly higher in the IFB group than in the TBNA group (1.67 vs. 1.50, p = 0.032) | ||
520 | |a CONCLUSIONS: Modified EBUS-IFB, combining standard-sized forceps with common EBUS-TBNA equipment, is feasible with few major complications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bronchoscopy | |
650 | 4 | |a Intranodal forceps biopsy | |
650 | 4 | |a Lymphadenopathy | |
650 | 4 | |a Transbronchial needle aspiration | |
700 | 1 | |a Matsumoto, Yuji |e verfasserin |4 aut | |
700 | 1 | |a Imabayashi, Tatsuya |e verfasserin |4 aut | |
700 | 1 | |a Tanaka, Midori |e verfasserin |4 aut | |
700 | 1 | |a Uchimura, Keigo |e verfasserin |4 aut | |
700 | 1 | |a Nakagomi, Takahiro |e verfasserin |4 aut | |
700 | 1 | |a Yanase, Komei |e verfasserin |4 aut | |
700 | 1 | |a So, Clara |e verfasserin |4 aut | |
700 | 1 | |a Ohe, Yuichiro |e verfasserin |4 aut | |
700 | 1 | |a Tsuchida, Takaaki |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiration; international review of thoracic diseases |d 1968 |g 102(2023), 2 vom: 20., Seite 143-153 |w (DE-627)NLM000076384 |x 1423-0356 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2023 |g number:2 |g day:20 |g pages:143-153 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000528644 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 102 |j 2023 |e 2 |b 20 |h 143-153 |